Shoulder Innovations, INC Form 4 insider transactions

Gilde Healthcare Holding B.V. increased its beneficial ownership in Shoulder Innovations, Inc. through preferred stock conversion and a common stock purchase.

A director at Shoulder Innovations, Michael A. Carusi, increased his beneficial ownership through conversions, purchases, and restricted stock unit awards.

SHOULDER INNOVATIONS, INC. CEO Robert Joseph Ball converted preferred stock into common stock ahead of the company's initial public offering.

Shoulder Innovations Director Richard Buchholz increased his direct beneficial ownership through a stock purchase and restricted stock unit award.

LSV Associates II and affiliated entities acquired 266,666 shares of Shoulder Innovations, Inc. common stock for $4 million and converted preferred shares into common stock.

David Lawrence Blue, Chief Customer Experience Officer of Shoulder Innovations, Inc., converted various preferred stock series into 43,937 common shares ahead of the company's initial public offering.

SHOULDER INNOVATIONS Director Kevin K. Sidow increased his direct beneficial ownership of common stock through a preferred stock conversion and RSU award.

Director and 10% owner Geoffrey B. Pardo reported significant common stock acquisitions and preferred stock conversions related to Shoulder Innovations, Inc.'s IPO.

A director at Shoulder Innovations, Paul Buckman, increased his direct common stock holdings through a preferred stock conversion and a restricted stock unit award.

SHOULDER INNOVATIONS' Chief Operating Officer, Matthew Ahearn, converted preferred stock into 67,242 common shares, increasing his direct beneficial ownership to 108,035 shares.

Director and 10% owner Casey M Tansey increased direct and indirect holdings in SHOULDER INNOVATIONS, Inc. following preferred stock conversions and a direct share purchase.

Shoulder Innovations CFO Jeffrey S. Points acquired 50 shares of common stock at $15 per share, including an indirect purchase by his son.